Position in MRK
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$61,354,636
+$28,853,296 QoQ
Shares Held
510,056
+65.2% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Derivatives in MRK
reported options exposure · as of Sep 30, 2022CallValue
$68,896
CallShares
800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026NATIXIS holds $547,855,762 across 11 Drug Manufacturers - General names. MRK ranks #4 (11.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
2,068,064 | $125,428,081 | |
| 2 | LLY |
ELI LILLY & Co
|
100,947 | $92,848,022 | |
| 3 | NVO |
Novo Nordisk A S
|
2,005,285 | $73,694,223 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
510,056 | $61,354,636 | |
| 5 | PFE |
Pfizer Inc
|
1,912,234 | $53,695,530 | |
| 6 | JNJ |
Johnson & Johnson
|
213,825 | $52,267,383 | |
| 7 | ABBV |
AbbVie Inc.
|
233,196 | $50,717,798 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
156,715 | $21,841,369 |
All Filings in MRK
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $61,354,636 | 510,056 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $32,501,340 | 308,772 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $72,962,195 | 869,322 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $47,569,460 | 600,928 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $130,428,281 | 1,453,078 | Shares | Sole | 2025-07-18 | |
| 2024-12-31 | $34,780,695 | 349,625 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $35,973,536 | 316,780 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $48,965,995 | 395,525 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $171,548,458 | 1,300,102 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $209,100,250 | 1,917,999 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $90,924,719 | 883,193 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $56,579,524 | 490,333 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $72,252,321 | 679,127 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $107,644,133 | 970,204 | Shares | Sole | 2023-02-24 | |
| 2022-09-30 | $68,896 | 800 | Call | Sole | 2022-11-14 | |
| 2022-09-30 | $274,434,470 | 3,186,652 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $33,842,030 | 371,197 | Shares | Sole | 2022-08-12 | |
| 2022-06-30 | $98,372 | 1,079 | Call | Sole | 2022-08-12 | |
| 2022-03-31 | $180,180,732 | 2,195,987 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $48,421,151 | 631,800 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $145,835,453 | 1,941,625 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $171,901,096 | 2,210,378 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $119,200,035 | 1,620,464 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $184,074,971 | 2,358,321 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $64,205,861 | 811,184 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $7,834,019 | 106,169 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $175,271,595 | 2,387,376 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||